Skip to content

We want to clarify that IG International does not have an official Line account at this time. We have not established any official presence on Line messaging platform. Therefore, any accounts claiming to represent IG International on Line are unauthorized and should be considered as fake.
CFDs are complex instruments. 72% of retail client accounts lose money when trading CFDs, with this investment provider. You can lose your money rapidly due to leverage. Please ensure you understand how this product works and whether you can afford to take the high risk of losing money.
CFDs are complex instruments. 72% of retail client accounts lose money when trading CFDs, with this investment provider. You can lose your money rapidly due to leverage. Please ensure you understand how this product works and whether you can afford to take the high risk of losing money.

Where now for FANG stocks?

Vaccine news prompted investors to flood back to value stocks yesterday, but is the great rally in FANG stocks over as a result?

Trader Source: Bloomberg

Tech suffers as value surges

Yesterday’s remarkable bounce in stock markets saw one big area left out of the party. Tech stocks suffered a poor day, with the Nasdaq 100 reversing on the day having leapt higher along with everyone else.

On many measures, high-growth names suffered their worst performance in months. FANG stocks, for so long the big winners, saw their worst day against the ‘average’ S&P 500 stock in four years, with a gap of almost 8%, while the Dow Jones enjoyed its best performance against the Nasdaq in twenty years.

The big winners from Monday’s soar away gains were those sectors that have suffered most in recent months, such as banks, travel stocks and energy names. These sectors have suffered heavily thanks to expectations of weaker demand for holidays, a drop in oil consumption and record-low interest rates. The vaccine news suggests that there will be some reversal in each of these trends, even if that reversal is some way off.

NDX chart Source: ProRealTime
NDX chart Source: ProRealTime

Is that it for FANG stocks?

As is the way of markets and the financial media, there was no shortage of commentators willing to declare the great ‘long FANG’ trade dead. On a short-term time frame, it does look like the big post-March rally in these stocks is at an end. But even on a five-year time frame yesterday’s weakness barely even registers.

FANG was a popular trade long before Covid-19, and with good reason. These big tech stocks have been market stars for years, thanks to their commanding market share and impressive levels of cash generation. In a world of low yields, high-growth stocks have been very much in demand.

Growth vs value

Are things about to change? Is value finally due to catch up with growth in terms of performance? Certainly, a steepening yield curve would support the idea of stronger growth in the economy and higher inflation, which may drive investors towards other sectors than technology.

Growth vs value
Growth vs value

But to keep things simple, most trends go on much longer than anyone expects. We might finally be at the point where the big tech rally begins to weaken, but the tech giants are still compelling investments even in a changing world. It would be silly to cut them out of a portfolio now on one day’s worth of vaccine news. It would be even more foolish to begin shorting them without clear evidence of a deterioration in fundamentals and/or their current bullish price momentum.

Learn more about how to trade stocks


This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.